Valaris Limited
VALValaris Limited is cheap for a reason. The P/E sits at the 17th percentile of its own range, and the quarters are still getting worse.
The sharpest disagreement: annual EPS moved +170.7% against a +72.6% price move — the market has not yet caught up with the delivery.
The price is in a confirmed uptrend (33 weeks in) while the P/E sits at the 17th percentile of its own 4-year range. Underneath, the last four quarters read deteriorating, and 53% of the last 3 years' profit arrived as cash. What settles it: whether the price catches up with earnings that have already moved.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Valaris Limited trades at $78.1, in a confirmed uptrend and 33 weeks into that stage. That is +2.5% against its own 200-day average. It sits at 55% of a 52-week range of $45 to $105. On relative strength it is currently behind the S&P 500 on a trailing-13-week view (12 weeks and counting).
Today the stock is in a confirmed uptrend — week 33 of stage 2. At $78.1 it trades +2.5% versus its 200-day average and sits at 55% of its 52-week range ($45–$105).
Against the market, two honest reads. Cumulative: over the last 5.2 years the stock moved +254% while the S&P 500 moved +83% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (12 weeks and counting; last ahead the week of 2026-05-15) — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of $1 of annual profit: how many dollars the market pays for each dollar the company earns in a year.
Valaris Limited trades at 5.5× P/E, near the bottom of its own range — cheaper only 17% of the time. Its long-run median P/E is 9.3×, measured across 4.1 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 5.5× is near the bottom of its own range — cheaper only 17% of the time, against a long-run median of 9.3× measured over 4.1 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
One caveat before moving on: margins are the best this company has ever printed — cheap against its own history on record margins is not the same thing as cheap. If profitability mean-reverts, today's multiple is higher than it looks.
Why the multiple sits where it does: over the past year annual EPS moved +170.7% against a +72.6% price move — earnings outran the price, pushing the multiple DOWN its own range.
The price move, decomposed: over 3y, of the +0.8%/yr price move, ~+108.3%/yr came from earnings growth and ~−107.5 pp from the multiple (compressing). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is low against its own past, so the story rests on the earnings line underneath it, not the multiple.
Stage: Improving Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Valaris Limited reads as improving on its fundamental arc. Improving — profit growth bottomed 3 quarters ago at −64.7% and has held its recovery at +233.3%, ROE lifting at 30.9%. The read is built from 12 quarters across 4 curves, on partial evidence.
Why it matters: a sustained climb off the trough is the setup this page is built to catch — the question moves to what you pay for it.
Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.
A partial read: at least one curve is short, or the returns curve is not the computed quarterly series — hold the stage word a little more loosely.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +0.4% | +14.0% | +10.6% | — |
| Profit | +164.9% | +75.9% | — | — |
| EPS | +170.7% | +81.2% | — | — |
| Stock price | +72.6% | +0.8% | +24.6% | — |
4-Factor Sector Score
43.2/100 — rank 7 of 10 in Oil & Gas Drilling · 64% evidence confidence
Valaris Limited scores 43.2 out of 100 against the 10 companies it is compared with in Oil & Gas Drilling, ranking 7. Price leads the evidence: RS versus the benchmark is -1.2%, but earnings trajectory is weak. Wait for revenue and profit confirmation.
The four contributions add to the total exactly: 9.1 + 9.8 + 11.1 + 13.2 = 43.2. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Valaris Limited reported $0.5 B of revenue in the Mar 26 quarter, −24.2% year on year. Over 5 years it has compounded at 10.6% a year. The last full year, FY25, came in at $2.4 B. The last four reported quarters add to $2.2 B.
FY25 revenue came in at $2.4 B (+0.4% on the year), capping 5 years at 10.6% compound. The latest quarter (Mar 26) printed $0.5 B, −24.2% year on year.
Pace check: the last four quarters averaged −8.9% growth against the decade's 10.6% — the current year is running slower than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew −9.0% over the last 4 quarters against +8.6%/yr over the last 8 — rolling over; TTM profit +233.3% vs +8.5%/yr — accelerating.
Operating margin Operating margin is what is left of every $100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Valaris Limited's operating margin is 4.3% in the Mar 26 quarter, −18.3 percentage points against the same quarter a year ago. That is the widest this company has ever printed on a full-year basis. Across 5 fiscal years the operating margin has ranged −302.1% to 20.3%. The current quarter sits inside that band.
The latest quarter's operating margin is 4.3%, −18.3 pp against the same quarter a year ago. Across 5 fiscal years the operating margin has ranged −302.1%–20.3%, and FY25's 20.3% is the top of that band — a record year.
🚨 Why the margin moved: operating margin went −18.3 pp year on year while gross margin went −14.8 pp — the loss came mostly from the gross line: input costs and pricing.
Worth repeating from the valuation section: cheap against its own history on record margins is not the same thing as cheap — a record margin flatters every ratio built on top of it.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Valaris Limited posted a net loss of $0.02 B in the Mar 26 quarter. Full-year FY25 profit was $1.0 B. That loss is 4.3% of the quarter's revenue. The same quarter a year earlier lost $0.04 B. 3 of the last 12 reported quarters were loss-making.
Mar 26 profit was $−0.0 B, null year on year. On the full year, FY25 printed $1.0 B (+164.9%).
Pace comparison, last four quarters: profit +214.6% vs revenue −8.9%. Profit is growing faster than sales — fixed costs are being spread over a bigger base, and each extra dollar of revenue drops more to the bottom line.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 53% of Valaris Limited's reported profit arrived as operating cash — a gap worth watching. In FY25 that was $0.6 B of operating cash against $1.0 B of profit. After $0.3 B of capital spending, $0.2 B was left as free cash. Cash resolution here is annual, because quarterly cash statements are not published.
FY25: operating cash of $0.6 B against reported profit of $1.0 B, leaving free cash of $0.2 B after $0.3 B of capital spending. Across the last 3 fiscal years the conversion rate is 53% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
🚨 Why: conversion is measured cleanly, but the working-capital day-counts behind it sit below what we hold — the move is shown without inventing its driver.
Router verdict: the visible cash user is investment — the next section checks what the spending is buying.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Valaris Limited does not report the debtor, inventory and payable day-counts a cash cycle is built from, so this section reads the investment side instead. Capital spending ran $2.0 B over the last 3 years. Averaged over those years that is 28.1% of FY25 revenue a year.
Working-capital day-counts are not in our numbers for this stock, so this section reads the investment side — where the cash is being put to work.
On the investment side: capital spending of $2.0 B over the last 3 fiscal years.
The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.
Return on equity Return on equity (ROE) is the profit the business earns on its shareholders’ money. With the full capital-employed split not in our numbers, ROE is the cleanest long ladder we can draw here.
Valaris Limited earns a ROE of 31% in FY25. That is up from a trough of 14% in FY22. Return on invested capital clears the cost of that capital by +0.7 percentage points, so growth here adds value rather than only size. The wiring behind it is 41.4% net margin on 0.45× asset turns.
FY25 ROE is 31%, recovered from a FY22 trough of 14% — the full ladder below shows the fall and the climb, undoctored.
Why the return is what it is — the wiring (FY25): 41.4% net margin × 0.45× asset turns × 1.67× balance-sheet leverage ≈ 31.1% on equity. Margin is doing the heavy lifting; leverage is a meaningful part of the equation.
The capstone test — ROIC − WACC: 9.6% − 8.9% = a +0.7 pp spread. The 8.9% is an estimate of this company's own cost of capital — read the sign and the size of the spread, not the decimals. Positive but thin — value creation with little room for error.
Dividend
Valaris Limited pays no dividend. Across the last 12 reported quarters it has declared no dividend per share, so there is no payout history to chart and no yield to quote. Companies at this stage typically reinvest earnings rather than distribute them, which makes the cash-flow and reinvestment sections the place that cash shows up.
Valaris Limited does not currently pay a dividend. Across the last 12 reported quarters the company has declared no dividend per share, so there is no payout history to chart and no yield to quote. Companies at this stage typically reinvest earnings instead of distributing them.
Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.
Valaris Limited carries total debt of $1.1 B against shareholder equity of $3.2 B as of Mar 26, a debt-to-equity of 0.34. On the annual view that ratio went from 0.51 in FY21 to 0.34 in FY25. Read the returns elsewhere on this page with that leverage in mind.
Mar 26: total debt of $1.1 B against shareholder equity of $3.2 B — a debt-to-equity of 0.34. On the annual view, debt-to-equity went from 0.51 (FY21) to 0.34 (FY25). Read the returns on this page with that leverage in mind.
Ownership There is no quarter-by-quarter holder register to read here, so we read the crowd through short interest — the slice of tradable shares currently sold short, positioned for a fall.
11.5% of Valaris Limited's tradable float is currently sold short — a large bloc is positioned against it. At typical trading volumes those positions would take about 6.3 days to buy back. There is no quarter-by-quarter holder register to read for this filer, so the crowd is read through short interest instead.
The latest reading: 11.5% of the float is sold short, and at typical trading volumes it would take about 6.3 days to buy those positions back. A large bloc is positioned against it. This is a single point-in-time reading — we do not yet hold its history, so we show no trend chart.
Why it sits there: who is doing the shorting, and why, does not travel with the number — the level is shown without inventing its story.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Valaris Limited: the Z-score reads 2.39. A Z-score above roughly 3 reads as safe and below roughly 1.8 as the distress zone, so this sits in the grey band between the two. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure.
Why it matters: a Z-score of 2.39 sits in the grey band — neither clearly safe nor clearly distressed.
The safety line in one sentence: the Z-score reads 2.39.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Nabors Industries Ltd.NBR | 59.1/100Thin evidence · provisional52% evidence | ASLEEP | 19.1/35 Revenue — · PAT — · OPM change 7 pp 45% evidence | 11.5/25 ROCE 1.4% · OPM 7.9% 76% evidence | 11.5/20 P/E 6.3× · PEG — 15% evidence | 17.0/20 RS sector 18.9% · RS bench 12% · 1Y 135.6%4 of 12 weeks ahead 70% evidence |
| Exact sum: 19.1 + 11.5 + 11.5 + 17 = 59.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 2Transocean Ltd.RIG | 53.9/100Mixed-positive evidence61% evidence | ASLEEP | 23.2/35 Revenue 12.9% · PAT — · OPM change 19.4 pp 62% evidence | 13.9/25 ROCE 1.8% · OPM 26.5% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 6.8/20 RS sector 0.3% · RS bench -4.8% · 1Y 68.4%0 of 12 weeks ahead 100% evidence |
| Exact sum: 23.2 + 13.9 + 10 + 6.8 = 53.9 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is 0.3% and the one-year return is 68.4%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 3Seadrill LimitedSDRL | 53.4/100Mixed-positive evidence64% evidence | ASLEEP | 19.5/35 Revenue 7.9% · PAT -118.8% · OPM change 1.3 pp 62% evidence | 11.1/25 ROCE 0.7% · OPM 6.7% 76% evidence | 8.9/20 P/E 65.7× · PEG — 15% evidence | 13.9/20 RS sector 2.7% · RS bench -0.7% · 1Y 45.6%1 of 12 weeks ahead 100% evidence |
| Exact sum: 19.5 + 11.1 + 8.9 + 13.9 = 53.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 4Patterson-UTI Energy, Inc.PTEN | 53.2/100Thin evidence · provisional58% evidence | ASLEEP | 17.8/35 Revenue — · PAT — · OPM change -2.6 pp 45% evidence | 6.0/25 ROCE -0.1% · OPM -1.3% 76% evidence | 10.4/20 P/E 33.4× · PEG — 15% evidence | 19.0/20 RS sector 17% · RS bench 10.7% · 1Y 85.8%3 of 12 weeks ahead 100% evidence |
| Exact sum: 17.8 + 6 + 10.4 + 19 = 53.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 5Noble Corporation plcNE | 51.6/100Thin evidence · provisional58% evidence | ASLEEP | 18.7/35 Revenue — · PAT — · OPM change 7.3 pp 45% evidence | 12.8/25 ROCE 0.4% · OPM 28.7% 76% evidence | 9.6/20 P/E 40.1× · PEG — 15% evidence | 10.5/20 RS sector 1.5% · RS bench -3% · 1Y 52.5%1 of 12 weeks ahead 100% evidence |
| Exact sum: 18.7 + 12.8 + 9.6 + 10.5 = 51.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 6Helmerich & Payne, Inc.HP | 44.3/100Mixed-negative evidence71% evidence | ASLEEP | 13.1/35 Revenue 29.7% · PAT -266.2% · OPM change -8.1 pp 83% evidence | 5.5/25 ROCE -0.6% · OPM -4% 76% evidence | 10.8/20 P/E 11.9× · PEG — 15% evidence | 14.9/20 RS sector 4% · RS bench 0.4% · 1Y 99.5%0 of 12 weeks ahead 100% evidence |
| Exact sum: 13.1 + 5.5 + 10.8 + 14.9 = 44.3 · Decision use: Price leads the evidence: RS versus the benchmark is 0.4%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 7Valaris Limitedthis pageVAL | 43.2/100Mixed-negative evidence64% evidence | ASLEEP | 9.1/35 Revenue -10% · PAT 100% · OPM change -18.7 pp 62% evidence | 9.8/25 ROCE 0.5% · OPM 4.3% 76% evidence | 11.1/20 P/E 6.9× · PEG — 15% evidence | 13.2/20 RS sector 4.5% · RS bench -1.2% · 1Y 66%0 of 12 weeks ahead 100% evidence |
| Exact sum: 9.1 + 9.8 + 11.1 + 13.2 = 43.2 · Decision use: Price leads the evidence: RS versus the benchmark is -1.2%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 8Precision Drilling CorporationPDS | 40.1/100Thin evidence · provisional52% evidence | ASLEEP | 15.6/35 Revenue — · PAT — · OPM change -5.1 pp 45% evidence | 11.0/25 ROCE 0.6% · OPM 7.5% 76% evidence | 8.5/20 P/E 703.5× · PEG — 15% evidence | 5.0/20 RS sector -6.4% · RS bench -9.9% · 1Y 38.7%0 of 12 weeks ahead 70% evidence |
| Exact sum: 15.6 + 11 + 8.5 + 5 = 40.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 9Borr Drilling LimitedBORR | 39.9/100Thin evidence · provisional58% evidence | ASLEEP | 12.8/35 Revenue 5.7% · PAT -35.3% · OPM change -9.2 pp 62% evidence | 13.1/25 ROCE 1.4% · OPM 18.6% 76% evidence | 10.0/20 P/E 38.5× · PEG — 15% evidence | 4.0/20 RS sector -11.2% · RS bench -15.7% · 1Y 85.3%0 of 12 weeks ahead 70% evidence |
| Exact sum: 12.8 + 13.1 + 10 + 4 = 39.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 10Sable Offshore Corp.SOC | 31.3/100Thin evidence · provisional40% evidence | BASING | 16.8/35 Revenue — · PAT — · OPM change — 4% evidence | 5.2/25 ROCE -11.5% · OPM — 61% evidence | 9.3/20 P/E 44.7× · PEG — 15% evidence | 0.0/20 RS sector -68.3% · RS bench -67.8% · 1Y -84.5%2 of 12 weeks ahead 100% evidence |
| Exact sum: 16.8 + 5.2 + 9.3 + 0 = 31.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led S&P 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Valaris Limited's stock price today?
Valaris Limited trades at $78.1, +72.6% over the past year. The company is valued at $5.0 B. The stock sits at 55% of its 52-week range of $45–$105, +2.5% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 33 weeks in. — as of 5 August 2026.
What were Valaris Limited's latest quarterly results?
Valaris Limited reported revenue of $0.5 B and a net loss of $0.0 B for the Mar 26 quarter. Earnings per share were $−0.24. The operating margin was 4.3%, 18.3 pp lower than a year earlier. — as of 5 August 2026.
What is Valaris Limited's revenue?
Valaris Limited reported revenue of $0.5 B in the Mar 26 quarter, −24.2% year on year. For the full FY25 fiscal year, revenue was $2.4 B (+0.4%). Over the last 5 years revenue compounded at 10.6% a year. — as of 5 August 2026.
What is Valaris Limited's profit?
Valaris Limited earned $−0.0 B of net profit in the Mar 26 quarter. Full-year FY25 profit was $1.0 B. The operating margin ran 4.3% in the latest quarter. — as of 5 August 2026.
What is Valaris Limited's market cap?
Valaris Limited's market capitalisation is $5.0 B at a stock price of $78.1. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 5 August 2026.
What is Valaris Limited's P/E ratio?
Valaris Limited trades at a P/E of 5.5×, at the 17th percentile of its own 4-year range, against a long-run median of 9.3×. This is a comparison with the stock's own history, not a value call — as of 5 August 2026.
Does Valaris Limited pay a dividend?
No — Valaris Limited has declared no dividend per share in any of its last 12 reported quarters, so there is no payout history and no yield to quote. That is a reading of the filed statements, not an estimate. — as of 5 August 2026.
Is Valaris Limited overvalued?
On its own history, Valaris Limited looks cheap against its own history: its P/E of 5.5× has been cheaper only 17% of the time in 4 years (long-run median 9.3×). That is a percentile read against the stock's own past, not a price opinion or a direction call. One caveat: margins are the best this company has ever printed — cheap on record margins is not the same thing as cheap. — as of 5 August 2026.
How is Valaris Limited performing?
Valaris Limited is in a confirmed uptrend, 33 weeks in. Against the S&P 500 it has been behind on a trailing-13-week view for 12 weeks. This describes what the data did, not a rating. — as of 5 August 2026.
What stage is Valaris Limited in?
Improving — profit growth bottomed 3 quarters ago at −64.7% and has held its recovery at +233.3%, ROE lifting at 30.9%. The read comes from the last 12 quarters of growth (revenue growth −9.0% latest, profit growth +233.3% latest, eps growth +235.2% latest) plus the ROE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 5 August 2026.
Is Valaris Limited in an uptrend?
Yes — the price is in a confirmed uptrend (week 33 of stage 2), trading +2.5% versus its 200-day average and at 55% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 5 August 2026.
Is Valaris Limited beating the market?
Not lately — on a trailing-13-week view Valaris Limited is currently behind the S&P 500 (12 weeks and counting; last ahead the week of 2026-05-15), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 5.2 years the stock moved +254% against the S&P 500's +83% — ahead of the index over the full window. — as of 5 August 2026.
Will Valaris Limited's stock price go up?
This page publishes no price forecast for Valaris Limited. What it measures instead: the stock price is $78.1, the price is in a confirmed uptrend 33 weeks in. Its P/E of 5.5× sits at the 17th percentile of its own 4-year range. — as of 5 August 2026.
Is the market betting against Valaris Limited?
Yes — short interest is 11.5% of Valaris Limited's tradable float, about 6.3 days to cover at typical volumes. A crowded short: a large bloc is positioned against it. With no quarter-by-quarter holder register here, short interest is the cleanest crowd read we hold — as of 5 August 2026.
Does Valaris Limited have too much debt?
It is moderate — Valaris Limited's debt-to-equity is 0.37. A year-by-year borrowings ladder is not in our numbers for this stock, so the latest reading is the cleanest hold. Read the returns on this page with that leverage in mind — as of 5 August 2026.
What is Valaris Limited's capex?
Valaris Limited spent $2.0 B on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY25 alone that was $0.3 B. — as of 5 August 2026.
What is Valaris Limited's cash flow?
Valaris Limited generated $0.6 B of operating cash flow in FY25 and $0.2 B of free cash flow after $0.3 B of capital spending. Reported profit that year was $1.0 B, so operating cash ran behind profit. — as of 5 August 2026.
Is Valaris Limited's profit real cash?
Not fully — over the last 3 fiscal years, 53% of Valaris Limited's reported profit arrived as operating cash. In FY25, operating cash was $0.6 B against reported profit of $1.0 B. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 5 August 2026.
How financially safe is Valaris Limited?
On the balance sheet, the Z-score reads 2.39 — above roughly 3 is safe, below roughly 1.8 is the distress zone. That is in the grey band — neither clearly safe nor clearly distressed. — as of 5 August 2026.
Where is Valaris Limited in its business cycle?
Valaris Limited's FY25 operating margin was 20.3%, against a 5-year band of −302.1%–20.3%: the top of the band — a record year. Record profitability is late-cycle territory: every ratio flatters at the top, and the story leans on margins holding. The latest quarter ran 4.3%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 5 August 2026.
What could break the Valaris Limited story?
The sharpest disagreement: annual EPS moved +170.7% against a +72.6% price move — the market has not yet caught up with the delivery. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 5 August 2026.
Is Valaris Limited a stock worth studying right now?
This is not investment advice. The machine read: Valaris Limited is cheap for a reason. The P/E sits at the 17th percentile of its own range, and the quarters are still getting worse. The sharpest open question: whether the price catches up with earnings that have already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 5 August 2026.